BrainAurora Medical Technology (HKG:6681) appointed Cai Longjun as its chief executive officer, with immediate effect, according to a Tuesday Hong Kong bourse filing.
Shares of the firm were down nearly 2% in midday Wednesday trade.
Cai has served as the group's chief technology officer and chief operating officer since 2022, overseeing product R&D and overall operations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments